Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerability.
作者信息
Belzer Annika, Pach Jolanta, Mortlock Ryland D, Clune James, Olino Kelly, Sznol Mario, Bhatia Aarti, Burtness Barbara, Christensen Sean, Leventhal Jonathan S
机构信息
Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
Department of Plastic Surgery, Yale School of Medicine, New Haven, Connecticut.
出版信息
JAAD Int. 2023 Feb 26;11:174-175. doi: 10.1016/j.jdin.2023.02.007. eCollection 2023 Jun.
Abstract
摘要
相似文献
1
Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerability.评估局部晚期和转移性基底细胞癌的药物治疗：一项单机构回顾性分析，探究疗效、安全性和耐受性。
JAAD Int. 2023 Feb 26;11:174-175. doi: 10.1016/j.jdin.2023.02.007. eCollection 2023 Jun.
2
Locally advanced basal cell carcinoma: Real-life data with sonidegib.局部晚期基底细胞癌：索立德吉的真实世界数据。
Dermatol Ther. 2022 Jun;35(6):e15441. doi: 10.1111/dth.15441. Epub 2022 Mar 21.
3
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.西妥昔单抗治疗后局部晚期基底细胞癌：一项开放标签、多中心、单臂、2 期临床试验。
Lancet Oncol. 2021 Jun;22(6):848-857. doi: 10.1016/S1470-2045(21)00126-1. Epub 2021 May 14.
4
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial.纳武利尤单抗（一种抗 PD-1 免疫疗法）治疗晚期基底细胞癌患者的安全性和疗效：在 sonic Hedgehog 抑制剂治疗失败或不耐受后的 UNICANCER AcSé NIVOLUMAB 试验。
Eur J Cancer. 2022 Dec;177:103-111. doi: 10.1016/j.ejca.2022.09.013. Epub 2022 Oct 11.
5
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study.索立德吉治疗晚期基底细胞癌的长期疗效和安全性：II 期随机、双盲 BOLT 研究的 42 个月分析。
Br J Dermatol. 2020 Jun;182(6):1369-1378. doi: 10.1111/bjd.18552. Epub 2019 Dec 8.
6
Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma.晚期基底细胞癌患者中刺猬通路抑制剂相关不良事件的特征与管理
Oncologist. 2016 Oct;21(10):1218-1229. doi: 10.1634/theoncologist.2016-0186. Epub 2016 Aug 10.
7
Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma. hedgehog 通路抑制治疗基底细胞癌。
Target Oncol. 2019 Jun;14(3):253-267. doi: 10.1007/s11523-019-00648-2.
8
Immune checkpoint inhibitors for advanced or metastatic basal cell carcinoma: how much evidence do we need?免疫检查点抑制剂治疗晚期或转移性基底细胞癌：我们需要多少证据？
Immunotherapy. 2021 Oct;13(15):1293-1304. doi: 10.2217/imt-2021-0089. Epub 2021 Aug 31.
9
Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients.晚期基底细胞癌经检查点抑制后重新诱导使用刺猬信号通路抑制剂：12例患者系列研究
Cancers (Basel). 2022 Nov 7;14(21):5469. doi: 10.3390/cancers14215469.
10
Vismodegib and Sonidegib in Locally Advanced and Metastatic Basal Cell Carcinoma: Update on Hedgehog Pathway Inhibitors.维莫德吉和索尼德吉治疗局部晚期和转移性基底细胞癌： hedgehog 通路抑制剂的最新进展。
Actas Dermosifiliogr. 2022 May;113(5):443-450. doi: 10.1016/j.ad.2022.01.005. Epub 2022 Jan 31.
引用本文的文献
1
Immunotherapy for locally advanced and metastatic basal cell carcinoma: a narrative review.局部晚期和转移性基底细胞癌的免疫治疗：一项叙述性综述。
Transl Cancer Res. 2024 Nov 30;13(11):6565-6575. doi: 10.21037/tcr-24-742. Epub 2024 Nov 6.
2
Case report: Sequential treatment strategy for advanced basal cell carcinoma in Gorlin-Goltz syndrome: integration of vismodegib, radiotherapy, surgery, and high-intensity focused ultrasound.病例报告：戈林-戈尔茨综合征中晚期基底细胞癌的序贯治疗策略：维莫德吉、放疗、手术及高强度聚焦超声的联合应用
Front Oncol. 2024 Jul 18;14:1428702. doi: 10.3389/fonc.2024.1428702. eCollection 2024.
本文引用的文献
1
Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study.帕博利珠单抗治疗晚期基底细胞癌：一项研究者发起的概念验证研究。
J Am Acad Dermatol. 2019 Feb;80(2):564-566. doi: 10.1016/j.jaad.2018.08.017. Epub 2018 Aug 24.
2
Emerging trends in the treatment of advanced basal cell carcinoma.新兴的晚期基底细胞癌治疗趋势。
Cancer Treat Rev. 2018 Mar;64:1-10. doi: 10.1016/j.ctrv.2017.12.009. Epub 2017 Dec 14.
3
Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies.Hedgehog 通路抑制剂治疗局部晚期和转移性基底细胞癌：干预性研究的系统评价和汇总分析。
JAMA Dermatol. 2016 Jul 1;152(7):816-24. doi: 10.1001/jamadermatol.2016.0780.
Zotero 插件